Have the economics of investing in new drug discovery and development become so unattractive that investment in new drugs will come to a halt? GlaxoSmithKline and other bio-pharmaceutical companies are turning to machine learning as a potential solution to make the drug discovery process more efficient, with the hopes of greatly reducing both the time and cost associated with R&D.
After the boom of Blockbuster(drugs with revenues exceeding $1B/yr) approvals in the 90’s, there has been a slowdown in the development of new drug entities (NDE). With drugs already in the market for easy to identify targets, research in academia […]
Machine learning has been touted as a potential cure-all for high drug prices. A number of leading biopharmaceutical companies like Roche have made some large bets in using artificial intelligence tools to improve drug development, but it remains to be seen if machine learning is living up to its hype.
In October 2017, reports surfaced stating that Amazon’s entry into healthcare was imminent. Overnight, stock prices for top pharmacies, PBMs, and wholesalers plummeted, losing a sum total of ~$40B in market capitalization .
But how well-equipped is Amazon to disrupt the entire healthcare supply chain?
Having worked as a healthcare consultant, and as a member of a family entrenched in the business of healthcare, I can say: this is one of the most critical unknowns facing the industry.
This post explores the steps Pfizer is taking to digitize its supply chain in order to better respond to evolving pharmaceutical industry dynamics, customer needs, and regulatory requirements.
In response to government mandates attacking the drug counterfeit epidemic, Pfizer has digitized its supply chain and is realizing significant efficiency improvements.
In 2016, 4 billion prescriptions were filled in retail pharmacies. Technology is changing this process.
Increasing pressure for domestic pharmaceutical production could require a shift away from overseas manufacturing. This creates an opportunity for contract manufacturing organizations like Patheon to provide domestic production services.
New legislation mandates that drugs be traceable at the unit level as they move through the pharmaceutical supply chain. AmerisourceBergen Corporation – a private label pharmaceutical manufacturer, distributor, wholesaler, and 3PL provider – is on the right track by prioritizing supply chain digitalization.
Can DHL use digital innovation to take advantage of the $13.4bn market opportunity in pharmaceutical cold chain logistics?